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in the nucleus of neurons. Hence, we tested whether tau might play a role in regulating the expres-
sion of certain genes by comparing gene expression in mice containing or lacking the tau protein.
Our results identiﬁed a signiﬁcant difference in the expression of the smarce1 gene, which codes
for the BAF-57 protein, a protein involved in the repression of neuron speciﬁc genes. These data sug-
gest a role for tau in neuron maturation.
 2010 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction
Tau is a microtubule associated protein that promotes tubulin
assembly in vitro [1], as well as stabilizing assembled microtubules
in cultured cells [2] by suppressing microtubule dynamics [3]. Tau
deﬁciency delays neurite extension in cultured neurons [4,5],
although the tau deﬁcient mice produced by gene-targeting are
viable and they do not show important cytoskeletal abnormalities
[5,6]. The mild phenotype of these mice could be due to functional
redundancy between tau and other microtubule-associated pro-
teins [7]. Nevertheless, delayed axonogenesis was observed in
tau deﬁcient neurons [6], a feature that has yet to be fully
explained.
Tau can also bind to nucleic acids [8–11] and it has been ob-
served in the nucleus of neuronal cells [12–14]. We conﬁrmed that
tau is indeed present in the nucleus of cells and hence, we tested
the possible inﬂuence of the tau protein on gene expression show-
ing that it can modify the expression of certain genes. We observed
differences in the level of smarce1 [15], which codes for BAF-57chemical Societies. Published by E
ecular ‘‘Severo Ochoa” (CSIC-
adrid, Campus Cantoblanco,[16], a protein involved in the repression of neuronal speciﬁc genes
[17] and whose expression is stimulated in tau deﬁcient mice.
2. Materials and methods
2.1. Animals
Tau/ mice were generated as described previously [6], cross-
ing heterozygous (Tau+/) mice to obtain homozygous tau knock-
out mice (Tau/) and control littermates (Tau+/+). 3 month-old
male mice were used in the experiments carried out here. The ani-
mals were bred at the Centro de Biologı´a Molecular ‘‘Severo Ochoa”
(Madrid, Spain) and they were maintained in accordance with the
institutional guidelines. Four to ﬁve mice were housed per cage in
a temperature controlled environment on a 12/12 h light-dark cy-
cle, with food and water available ad libitum.
2.2. Primary hippocampal cultures
Hippocampal cell cultures were prepared from 17-day-old
mouse fetuses according to modiﬁed versions of established proce-
dures [18]. Brieﬂy, the hippocampus was dissected out from each
pup and dissociated individually with the papain dissociation sys-
tem (Worthington Biochemical Corp.; Lakewood, NJ). The cells
recovered were plated on poly lysine-coated (1 mg/ml) coverslipslsevier B.V. All rights reserved.
Fig. 1. Tau protein is not only present in the cytoplasm but also in the nucleus of
cells. Western blot of the cytoplasmic and nuclear fractions from the hippocampus
of two wild-type mice. The 7.51 antibody detected tau, both in the cytoplasm and in
the nucleus, whereas tubulin was only present in the cytoplasmic fraction and
laminB only in the nucleus. The interaction with other tau antibodies (Tau-1, Tau-5
and AT100) was also done, with similar result.
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Glutamine, 1% penicillin/streptomycin. After 4 h, the medium was
replaced by the maintenance medium: Neurobasal medium (Invit-
rogen) supplemented with 2% B-27, 1% N2, 0.5 mM Glutamine,
1 mM pyruvate, 1% penicillin/streptomycin.
2.3. Immunoﬂuorescence
After 24 and 48 h in culture, the hippocampal cells were ﬁxed
for 20 min with warm 4% paraformaldehyde in PBS containing 4%
sucrose. After several washes with PBS, the cells were permeabili-
zed in 0.1% Triton X-100 for 15 min and they were then treated
with 1 M glycine for 30 min to eliminate any autoﬂuorescence.
After a brief wash with PBS, the cells were blocked with 1% BSA/
PBS for 1 h and then they were exposed to the primary antibodies
diluted in 1% BSA/PBS for 1 h: an antibody against Smi-31 (1:1000;
Sternberger) as an axonal marker and anti-b-III-tubulin (1:2000;
Covance) as a neuronal marker. Subsequently, the cultures were
washed extensively and then incubated for 45 min with the appro-
priate secondary antibody conjugated with either ﬂuorescein iso-
thiocyanate or with TexasRed (Jackson Laboratories, West Grove,
PA). After washing, the cells were mounted immediately with Flu-
orosave Reagent (Calbiochem) and the coverslips were analyzed on
an Axioskop2 plus microscope (Zeiss) using an Image J Software to
determine the axon length.
2.4. Western blotting
Hippocampal and kidney extracts from 3 month-old mice were
prepared in ice-cold extraction buffer consisting of: 20 mM HEPES
pH 7.4, 100 mM NaCl, 10 mM NaF, 1% Triton X-100, 1 mM sodium
orthovanadate, 10 mM EDTA, and protease inhibitors (10 lg/ml
aprotinin, 10 lg/ml leupeptin and 10 lg/ml pepstatin). The tissue
samples were homogenized at 4 C and the protein content was
determined by the Bradford method (Biorad). Subsequently, pro-
tein extracts and the subcellular fractions samples were resolved
on 10% SDS polyacrylamide gels and transferred to a nitrocellulose
membrane (Schleicher & Schuell). The membranes were probed
with the following primary antibodies: anti-BAF57 (1:1000; Sig-
ma); 7.51 (1:1000; from Dr. Claude Wischik, UK) that reacts with
phosphorylated as well as non-phosphorylated forms of tau within
the tubulin binding region; Tau-1 (1:1000; Chemicon) that detects
dephosphorylated tau; Tau-5 (1:1000; Calbiochem) that recog-
nizes the central region of tau in both the phosphorylated and
the non-phposphorylated forms; AT100 (1:500; Innogenetics) to
detect phosphorylated tau; anti a-tubulin (1:1000; Sigma) as a
cytoplasmic marker; and anti-laminB1 (1:200; Santa Cruz) as a nu-
clear marker. The membranes were incubated with the antibodies
at 4 C overnight in 5% non-fat dried milk, and the immunoreactive
bands were detected with the corresponding secondary antibodies
(1/5000; GIBCO) and visualized by ECL (Amersham Biosciences).
The quantiﬁcation of BAF57 was performed by densitometric scan-
ning and the values were normalized to those obtained with an
anti-b-actin antibody (1:5000; Sigma) to correct for deviations in
protein loading.
2.5. Subcellular fractionation
To prepare nuclear and cytosolic extracts, tissues were dis-
rupted with 15 strokes of an ice Dounce-homogenizer in M-SHE
buffer (210 mM manitol, 70 mM sucrose, 10 mM HEPES [pH 7.4],
1 mM EDTA, 1 mM EGTA) supplemented with protease inhibitors
(1 mM phenylmethylsulfonyl ﬂuoride, 10 lg/ml aprotinin, 10 lg/
ml leupeptin, 10 lg/ml pepstatin), phosphatase inhibitors (1 mM
sodium orthovanadate, 30 mM glycerophosphate, 5 mM pyro-
phosphate, 1 lM okadaic acid) and 1 mM dithiothreitol. Thehomogenate was placed on ice for 30 min and then centrifuged
at 1200g for 10 min at 4 C. The resulting pellet was homoge-
nized and centrifuged again as above, and the supernatant was
added to that obtained in the ﬁrst step to constitute the cytosolic
fraction. The membrane fraction (pellet) was homogenized in
M-SHE buffer and centrifuged at 1000g for 10 min at 4 C. Both
the supernatant and the pellet’s upper layer were discarded and
the remaining pellet, which contained the nuclei, was resus-
pended in TSE buffer (10 mM Tris [pH 7.5], 300 mM sucrose,
1 mM EDTA) supplemented with 0.1% NP-40. This suspension
was centrifuged at 8500g for 10 min at 4 C, and the resulting
pellet was resuspended in TSE buffer supplemented with 1% NP-
40 and centrifuged at 1500g for 7 min at 4 C. This last step
was repeated to clean the nuclear fraction (the opaque layer at
the bottom of the tube) of any other membranes (yellow layer).
Finally, lysis buffer (50 mM Tris–HCl [pH 6.8], 100 mM b-mercap-
toethanol, 2% SDS, 0.1% bromophenol blue, 10% glycerol) supple-
mented with protease and phosphatase inhibitors, was added to
cytosolic and nuclear fractions, and the samples were boiled for
10 min before they were analyzed by SDS–PAGE.
2.6. Gene expression analysis
For transcriptional analysis, hippocampal tissue from Tau/
mice and control littermates (n = 3 per group) was analyzed on
an Affymetrix MOE 430A 2.0 GeneChip, which analyzes 14,000
annotated mouse genes. The preparation of RNA, hybridization,
staining, and scanning of the GeneChipMOE 430A 2.0 was carried
out by Progenika Biopharma (Derio, Spain).
2.7. RNA isolation and quantitative real-time PCR
RNA was isolated from the hippocampus of Tau/ mice and
control littermates (n = 6 animals per genotype) using the Abso-
lutely RNA MiniPrep Kit (Stratagene). This RNA was used as a tem-
plate for the ﬁrst strand cDNA synthesis (Roche), which was then
analyzed by quantitative real-time PCR with an applied biosystems
ABI PRISM 7900HT real-time detection systemwith the SYBR green
PCR master mix (Applied Biosystems), interpreting the results with
the SDS 2.1 software. The primers used to amplify each gene were:
50-CACTTCTCCCATCTTTCGCT-30 and 50-GGGACTTAATGGCAGCT
GAG-30 for mapt; 50-TCCTTTTCCTCAAGTGATTTGG-30 and 50-AACA
E. Gómez de Barreda et al. / FEBS Letters 584 (2010) 2265–2270 2267CATCTTTGTCTTATTTCTTTTCA-30 for calbindin; 50-ATGCCCTTCT
CAGTCCTCTG-30 and 50-GGAAAGTCACAGGTGGAGGA-30 for
lsm120homolog; 50-TGGCTTTCCAAAGACACGAT-30 and 50-TCCATTA
TAAGAACATTCCATTCCT-30 for smarce1; 50-TGGGAGTTCTGGT
CAGGTTC-30 and 50-CCTAATCCACTGGGGACTGA-30 for map1lc3a.
Mean Ct values of gene expression were normalized to the mean
expression of b-actin in each sample.Table 1
Overexpressed and downregulated genes detected in the Affymetrix Mouse GeneChip. These
in the hippocampus of tau/ mice when compared to the wt mice (three animals per gen
Probeset ID Gene title
Down regulated
1424719 Microt. prot. tau
1448738 Calbidin 28 k
Overexpressed
1427998 LSM12 homolog
1422676 SW1/SNF relat., matrix cell, actin (BAF57)
1451290 Microtubule assoc. prot. 1 light ch.3
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Fig. 2. Microarray validation by quantitative real-time PCR. (A) Mouse chromosome 11
these three genes are located in the same region, they are not contiguous. (B) Quantitative
signiﬁcantly in tau deﬁcient mice when compared to wt mice (ﬁvefold; ***p < 0.001, St
difference was not statistically signiﬁcant. (C) Quantitative real-time PCR for upregulated
t-test) in Tau/ mice when compared to wtmice. The expression ofmap1lc3a and the lsm
expressed as percentage of control. Data shown are the mean ± S.E. of six animals per g3. Results
3.1. Tau is located in the nucleus of neuronal cells
Tau protein was ﬁrst discovered as a microtubule-associated
protein [1] and as a result, it has been considered as a cytoplasmic
protein like tubulin, themain component ofmicrotubules.However,ﬁve genes were selected from 265 genes whose expression was signiﬁcantly different
otype).
Gene symbol P-value Fold change
mapt 0.0000038 5.42043
calb1 0.00196123 1.26513
lsm12 0.00126384 2.34947
smarce1 0.0170026 1.16013
map1lc3a 0.763173 1.14813
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ideogram showing the locations of mapt, smarce1 and lsm12 homologue. Although
real-time PCR for downregulated genes. As expected, tau gene expression decreased
udent’s t-test). Calbindin mRNA levels were slightly lower in Tau/ mice but the
genes. We conﬁrmed smarce1 gene was overexpressed (twofold; *p < 0.05, Student’s
12 homologue did not change signiﬁcantly between Tau/ and wtmice. Results are
enotype.
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and there are different reports indicating that a small proportion
of tau is also present in the nucleus of cells [12–14]. We performed
subcellular fractionation to conﬁrm the presence of tau in the cell
nucleus, as well as in the cytoplasm [19], using a-tubulin as a cyto-
plasmic marker and laminB as a marker of the nuclear fraction. Tau
proteinwas clearly present in both cellular compartments, although
there was less in the nuclear fraction. By contrast, tubulin was only
present in the cytoplasmic fraction and laminB was only found in
the nuclear fraction (Fig. 1).
Little is known about the possible function of tau in the nucleus
[9], although it is known to be able to interact with chromatin and
nucleic acids [10–14,20]. This nuclear localization may be compat-
ible with a possible inﬂuence of the tau protein on gene expression.
Thus, we studied whether tau might regulate the expression of
speciﬁc genes.
3.2. Changes in gene expression in tau deﬁcient mice
We set out to look for possible differences in gene expression
between mice expressing or lacking the tau protein by using a
mouse GeneChip platform (Affymetrix) as a high throughput
technique to analyze gene expression. When RNA pools from
Tau/ and Tau+/+ mice were compared (Table 1) there was a dra-
matic decrease in tau gene expression in Tau/ mice, as expected
(which served as a positive control for the analysis). In addition,
slight changes in the expression of other genes were found,
including: smarce1 (coding for the BAF57 protein), calbindin, the
lsm12 homologue, or map1lc3a. Curiously, some of these geneswt Tau -/-
BAF57
β-actin
HIPPOCAMPUS
BAF57
β-actin
Tau-/-wt
KIDNEY
BAF57-1
BAF57-3
BAF57-5
A
B
C
N
N
N
Fig. 3. The BAF57 protein is overexpressed in the hippocampus but not in the kidney of t
by western blotting (n = 6 animals per genotype). Immunodetection with an anti-BAF57
expressed in the mouse nervous system (see C). Total BAF57 was signiﬁcantly increased
antibody against BAF57 only detected one protein isoform in kidney extracts and the leve
main BAF57 isoforms expressed in the mouse nervous system. The longest BAF57-1 isofoare located on chromosome 11 like the tau gene, although they
are not contiguous (Fig. 2A). Real-time PCR analysis was per-
formed on these transcripts to validate the data obtained from
the microarrays (Fig. 2B and C). No signiﬁcant differences were
found in the expression of each of these different genes, except
for the tau gene and smarcel. When the accumulation of the cor-
responding proteins was assessed in western blots, clear differ-
ences were only found in the tau protein, as well as slight
differences in smarce1 expression. When the presence of the
BAF57 protein (the product of smarce1 gene) was further investi-
gated, there was a difference in the expression of the isoform
with lower electrophoretic mobility (Fig. 3A). This difference
was only found in the brain but not in the kidney of Tau/ mice
(Fig. 3B) and indeed, the three main BAF57 isoforms found in
adult mouse brain were evident (Fig. 3C). These isoforms contain
some exons similar to those found for human BAF57 isoforms
whereas in other tissues, like the kidney, only the slower migrat-
ing isoform was found in mice [21]. However, when we tested
whether there were changes in this isoform in the kidney of
Tau/ mice, no differences were found in the only isoform pres-
ent (the longest one, Fig. 3B).
All three mouse BAF57 isoforms were expressed in the brain of
wild type and tau deﬁcient mice (Fig. 3A) and there was an in-
crease in the total amount of the three BAF57 isoforms in Tau/
when compared to wild type mice. In addition, a decrease in the
proportion of the two isoforms of higher electrophoretic mobility
was observed, isoforms mainly present in neuronal tissue, when
compared to the slower migrating ubiquitously expressed BAF57
isoform.**
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Mouse Time culture % cells bearing axons
Total axonal 
length (µm)
Wt 24h 44 ± 2 66 ± 3
Tau-/- 24h 15 ± 3 50 ± 2
Wt 48h 98 ± 2 147 ± 3
Tau-/- 48h 81 ± 3 108 ± 3
A
B
Wt Tau-/-
Fig. 4. Axonogenesis is delayed in tau deﬁcient neurons. (A) Immunoﬂuorescence
of 1DIV primary hippocampal neurons from Tau/ mice and control littermates
labeled with the Smi-31 (green) and b-III-tubulin (red) antibodies. (B) The
percentage of cells bearing axons and the axon length were measured in Tau/
and control neurons at 24 and 48 h (n = 80 cells per group).
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BAF57 (BRG1-associated factor 57) is a component of the mam-
malian SWI/SNF ATP-dependent chromatin remodelling complex
[16,22], which is involved in transcriptional regulation. Moreover,
BAF57 interacts with CoREST, a protein that acts as a co-repressor
of REST (RE1 silencing transcription factor), a transcription factor
which represses neuronal genes in non-neuronal cells [17]. We
have just indicated that an increase in BAF57 could produce a de-
crease (or delay) in the appearance of a neuronal morphology in
tau deﬁcient cells. Indeed, a delay in axon extension was reported
earlier in primary cultures of tau deﬁcient neurons [6]. These re-
sults have been now conﬁrmed in similar experiments (Fig. 4),
where a decrease in the proportion of cells bearing axons at stage
III [23] was observed in primary hippocampal cultures of Tau/
mice, although more than 80% of neurons from either source had
extended neurites after 48 h in culture.
4. Discussion
We have shown here that the tau protein may be found in the
cytoplasm or in the nucleus of a cell and that it may be capable
of regulating gene expression. Thus, we tested the changes in gene
expression in the wt and Tau/ mice brain. In the absence of tau,
changes in the expression of some genes were observed. As ex-
pected a dramatic decrease in mapt expression was seen, but also
we detected changes in smarce1, calbindin, the homologue of the
lsm120yeast gene and in themap10light chain 3awere also observed.
Smarce1 encodes the BAF-57 protein, which interacts with coR-
EST, a protein that forms a complex with the class I HDAC. The
interaction of BAF-57 with coREST facilitates the activity of the
transcriptional repressor REST, which blocks the expression of neu-
ronal speciﬁc genes in non-neuronal cells [17]. Calbindin is a cal-
cium binding protein that appears to buffer the excess of that
cation [24]. Curiously, calbindin gene is one of the genes repressed
by REST complex [25]. Thus, an increase in smarcel gene expression
is compatible with a decrease in calbindin gene expression, as
found in Table 1. The homologue of the Lsm-12 yeast gene appears
to play a role in protein translation, although little is known about
its possible function in neurons [26,27]. Finally, MAP1-light chain
3a is a cytoskeletal protein [28] and it has previously been sug-
gested that the amount of MAP1A increases in tau deﬁcient mice
[5].Here, we focused our analysis on the differential expression of
smarce1 since, unlike the other genes, the genechip data for this
gene was validated by RT-PCR and in Western blots. Since the
smarce1 gene is located on mouse chromosome 11, like the tau
gene, the differences in its expression may be due to an artifact
produced when generating the Tau/ mice [6]. However, the fact
that these genes do not lie close together on chromosome 11 and
that the differences for BAF57 (smarcel product) are speciﬁc to
the brain and they are not found in the kidney, suggest that the
changes in the level of smarce1 gene expression in the brain could
be produced speciﬁcally by the absence of tau.
In addition, the delay in axonogenesis observed in hippocampal
neurons from Tau/ mice suggests that the absence of tau protein
facilitates a non-neuronal phenotype. This observation agrees well
with previous ﬁndings indicating a delayed maturation of neuronal
precursors in Tau/ mice [29]. Tau is not essential for the non-
neural phenotype, probably because REST expression might be
important for the correct temporal execution of neuronal differen-
tiation programs, although it is not required for neuronal commit-
ment per se [30].
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